SMTL ID : 9c10.1

AMG 193, a clinical stage MTA-cooperative PRMT5 inhibitor, drives anti-tumor activity preclinically and in patients with MTAP-deleted cancers

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.85 Å
Oligo State
hetero-1-1-mer
Ligands
2 x GOL: GLYCEROL(Non-functional Binders)
1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
1 x 01: (4-amino-1,3-dihydrofuro[3,4-c][1,7]naphthyridin-8-yl){(3S)-3-[4-(trifluoromethyl)phenyl]morpholin-4-yl}methanone
1 x MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Belmontes, B. et al., AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients With MTAP-Deleted Cancers. Cancer Discov (2024)
Release Date
2024-10-02
Peptides
Protein arginine N-methyltransferase 5: A
Methylosome protein 50: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Protein arginine N-methyltransferase 5

Methylosome protein 50

Related Entries With Identical Sequence

4gqb.1 | 5fa5.1 | 5fa5.2 | 5fa5.3 | 5fa5.4 | 6ckc.1 | 6ugh.1